1.10. Analysis.
Comparison 1 Oral misoprostol versus no uterotonic/placebo (subgroups by dose), Outcome 10 Third stage >= 30 minutes.
Comparison 1 Oral misoprostol versus no uterotonic/placebo (subgroups by dose), Outcome 10 Third stage >= 30 minutes.